Azithromycin
Brand names: Zithromax
Azithromycin is a macrolide antibiotic with a long tissue half-life, used for respiratory, ENT, certain sexually transmitted and other infections, which allows short courses.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
US labelling (FDA)
Reference — US labelling, may differ from UK• Adult Patients ( ) Infection Recommended Dose/Duration of Therapy Community-acquired pneumonia (mild severity) Pharyngitis/tonsillitis (second-line therapy) Skin/skin structure (uncomplicated) 500 mg as a single dose on Day 1, followed by 250 mg once daily on Days 2 through 5. Acute bacterial exacerbations of chronic bronchitis (mild to moderate) 500 mg as a single dose on Day 1, followed by 250 mg once daily on Days 2 through 5 or 500 mg once daily for 3 days. Acute bacterial sinusitis 500 mg once daily for 3 days. Genital ulcer disease (chancroid) Non-gonococcal urethritis and cervicitis One single 1 gram dose. Gonococcal urethritis and cervicitis One single 2 gram dose. • Pediatric …
Source: US FDA prescribing information (openFDA / DailyMed), label dated 2026-03-16. Accessed 2026-06-12. US dosing and indications can differ from UK practice — use UK sources for prescribing decisions.
Clinical monograph
How it works
It inhibits bacterial protein synthesis at the 50S ribosomal subunit.
Prescribing in practice
- It prolongs the QT interval — use caution with other QT-prolonging drugs and in electrolyte disturbance.
- It has fewer CYP interactions than clarithromycin, but not none.
- Its long half-life means the antibacterial effect persists after the short course ends.
Monitoring
Short courses need no routine monitoring; consider ECG/electrolytes where QT risk is high.
Counselling the patient
- Complete the (often short) course.
- Gastrointestinal upset is common.
- Tell your clinician about heart-rhythm problems or other medicines.
Evidence & guidelines
Used per local antimicrobial guidance, valued for short courses; QT precautions apply.
Reference: MHRA Drug Safety Update (2013) Azithromycin QT; NICE NG84; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- FeverPAIN Score for Strep Throat · Throat
- Jarisch-Herxheimer Reaction Severity Assessment · Treatment Reactions
- PID Severity (CDC Diagnostic Criteria) · Gynaecological Infections
- Gustilo-Anderson Classification (Open Fractures) · Fracture Classification
- DRIP Score for Drug-Resistant Pneumonia · Pneumonia
- Adult Upper Airway Obstruction (Stridor) · DAS 2015 unanticipated difficult airway; RCEM
- Epistaxis Management · ENT-UK / NICE
- Acute Otitis Media · NICE NG91 2018
- Tonsillitis and Sore Throat · NICE NG84 2018
- Benign Paroxysmal Positional Vertigo · NICE CG124 / AAO-HNS Guidelines
- Acute Rhinosinusitis · NICE NG79 2017 / EPOS 2020